Modafinil reverses hypoexcitability of the motor cortex in narcoleptic patients: A TMS study

Sleep Medicine

Volumn 11, Issue 9, 2010, Pages 870-875

  Nardone, Raffaele ^a,b   Bergmann, Jürgen ^a,c   Lochner, Piergiorgio ^b   Caleri, Francesca ^b   Kunz, Alexander ^a   Staffen, Wolfgang ^a   Tezzon, Frediano ^b   Ladurner, Gunther ^a   Trinka, Eugen ^a   Golaszewski, Stefan ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b FRANZ TAPPEINER HOSPITAL   (Italy)

^c UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Epworth Sleepiness Scale; Intracortical inhibition; Modafinil; Motor threshold; Multiple Sleep Latency Test; Narcolepsy; Transcranial magnetic stimulation

Indexed keywords

MODAFINIL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPWORTH SLEEPINESS SCALE; EXCITABILITY; FACILITATION; FEMALE; GABAERGIC TRANSMISSION; HAND TREMOR; HUMAN; MALE; MORNING DOSAGE; MOTOR CORTEX; MOTOR NERVE CONDUCTION; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; NERVOUS SYSTEM PARAMETERS; NERVOUSNESS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RESTING MOTOR THRESHOLD; SHORT LATENCY INTRACORTICAL INHIBITION; SIDE EFFECT; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; NARCOLEPSY; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 79960542245     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.05.007     Document Type: Article

References (50)

1. Overeem S., Mignot E., van Dijk J.G., Lammers G.J. Narcolepsy: clinical features, new pathologic insights, and future perspective. J Clin Neurophysiol 2001, 18:78-105.
2. Bastuji H., Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry 1988, 12:695-700.
3. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol 1998;43:88-97.
4. Duteil J., Rambert F.A., Pessonnier J., Hermant J.F., Gombert R., Assous E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur J Pharmacol 1990, 180:49-58.
5. Ferraro L., Tanganelli S., O'Connor W.T., Antonelli T., Rambert F., Fuxe K. The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett 1996, 220:5-8.
6. Tanganelli S., Ferraro L., Bianchi C., Fuxe K. 6-Hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig. Neurosci Lett 1994, 171:201-214.
7. Tanganelli S., Perez de la Mora M., Ferraro L., Mendez-Franco J., Beani L., Rambert F.A., et al. Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins. Eur J Pharmacol 1995, 273:63-79.
8. Volkow N.D., Fowler J.S., Logan J., Alexoff D., Zhu W., Telang F., et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 2009, 301:1148-1154.
9. Ziemann U. TMS and drugs. Clin Neurophysiol 2004;115:1717-29 [Review].
10. Oliviero A., Della Marca G., Tonali P.A., Pilato F., Saturno E., Dileone M., et al. Functional involvement of cerebral cortex in human narcolepy. J Neurol 2005, 252:56-61.
11. Carskadon M.A., Dement W.C., Mitler M.M., Roth T., Westbrook P.R., Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986, 9:519-525.
12. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
13. American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic and coding manual, 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
14. Rossini P.M., Barker T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application: report of IFCN committee. Electroenceph Clin Neurophysiol 1994, 91:79-92.
15. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 1993, 471:501-519.
16. Huang Z.L., Qu W.M., Mochizuki T., Eguchi N., Watanabe T., Urade Y., et al. Arousal effect of orexin A depends on activation of the hystaminergic system. PNAS 2001, 98:9965-9970.
17. Jang I.S., Rhee J.S., Watanabe T., Akaike N., Akaike N. Histaminergic modulation of GABAergic transmission in rat ventromedial hypothalamic neurones. J Physiol 2001, 534:791-803.
18. Vincent S.R., Hokfelt T., Skirboll L.R., Wu J.Y. Hypothalamic gammaaminobutyric acid neurons project to the neocortex. Science 1983, 220:1309.
19. Liepert J., Allstadt-Schmitz J., Weiller C. Motor excitability and motor behaviour after modafinil ingestion-a double-blind placebo-controlled cross-over trial. J Neural Transm 2004, 111:703-711.
20. Lange R., Volkmer M., Heesen C., Liepert J. Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 2009, 256:645-650.
21. Ellis C.M., Monk C., Simmons A., Lemmens G., Williams S.C., Brammer M., et al. Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Action of modafinil. J Sleep Res 1999, 8:85-93.
22. Minzenberg M.J., Watrous A.J., Yoon J.H., Ursu S., Carter C.S. Modafinil shifts human locus coeruleus to low-tonic, high-phasis activity during functional MRI. Science 2008, 322:1700-1702.
23. Joo E.Y., Seo D.W., Tae W.S., Hong S.B. Effect of modafinil on cerebral blood flow in narcolepsy patients. Sleep 2008, 31:868-873.
24. Saletu M., Anderer P., Saletu-Zyhlarz G.M., Mandl M., Arnold O., Zeithofer J., et al. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. J Neurol 2004, 251:1354-1363.
25. Saletu M., Anderer P., Saletu-Zyhlarz G.M., Mandl M., Saletu B., Zeitlhofer J. Modafinil imprives information processing speed and increases energic resources for orientation of attention in narcoleptics: double-blind, placebo-controlled ERP studies with low-resolution brain electromagnetic tomography (LORETA). Sleep Med 2009, 10:850-858.
26. Civardi C., Collini A., Monaco F., Cantello R. Applications of transcranial magnetic stimulation in sleep medicine. Sleep Med Rev 2009, 13:35-46.
27. Ziemann U., Lonnecker S., Steinhoff B.J., Paulus Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study. Ann Neurol 1996, 40:367-378.
28. Di Lazzaro V., Oliviero A., Meglio M., Cioni B., Tamburrini G., Tonali P., et al. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol 2000, 111:794-799.
29. Ilic T.V., Meintzschel F., Cleff U., Ruge D., Kessler K.R., Ziemann U. Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity. J Physiol 2002, 545:153-167.
30. Tanganelli S., Fuxe K., Ferraro L., Janson A.M., Bianchi C. Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms. Naunyn Schmiedeberg Arch Pharmacol 1992, 345:461-465.
31. Ferraro L., Antonelli T., O'Connor W.T., Tanganelli S., Rambert F.A., Fuxe K. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett 1998, 253:135-138.
32. Ferraro L., Antonelli T., Tanganelli S., O'Connor W.T., Perez de la Mora M., Mendez-Franco J., et al. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 1999, 20:347-356.
33. Huang Y.S., Guilleminault C. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate. Pediatr Neurol 2009, 41:9-18.
34. Black J., Pardi D., Hornfeldt C.S., Inhaber N. The nightly administration of sodium oxybate results in significant reduction in the nocturnal disruption of patients with narcolepsy. Sleep Med 2009, 10:829-835.
35. Deisz R.A. The GABA(B) receptor antagonist CGP 55845A reduces presynaptic GABA(B) actions in neocortical neurons of the rat in vitro. Neuroscience 1999, 93:1241-1249.
36. Jones E.G. The thalamus 2007, Cambridge University Press, Cambridge, UK. 2nd ed.
37. Steriade M., Parent A., Hada J. Thalamic projections of nucleus thalami of cat: a study using retrograde transport of horseradish peroxidase and fluescent tracers. Comp Neurol 1994, 229:531-547.
38. Steriade M. Corticothalamic resonance, states of vigilance and mentation. Neuroscience 2000, 101:243-276.
39. Contreras D., Timofeev I., Steriade M. Mechanisms of long-lasting hyperpolarizations underlying slow sleep oscillations in cat corticothalamic networks. J Physiol 1996, 494:251-264.
40. Steriade M., Timofeev I., Grenier F. Natural waking and sleep states: a view from inside neocortical neurons. J Neurophysiol 2001, 85:1969-1985.
41. Timofeev I., Contreras D., Steriade M. Synaptic responsiveness of cortical and thalamic neurones during various phases of slow sleep oscillation in cat. J Physiol 1996, 494:265-278.
42. Timofeev I., Grenier F., Steriade M. Disfacilitation and active inhibition in the neocortex during the natural sleep-wake cycle: an intracellular study. PNAS 2001, 98:1924-1929.
43. Broughton R., Valley V., Aguirre M., Roberts J., Suwalski W., Dunham W. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective. Sleep 1986, 9(1 Pt. 2):205-215.
44. Urbano F.J., Leznik E., Llinás R.R. Modafinil enhances thalamocortical activity by increasing neuronal electronic coupling. Proc Natl Acad Sci USA 2007, 104:12554-12559.
45. Amassian V.E., Stewart M., Quirk G.J., Rosenthal J.L. Physiological basis of motor effects of a transient stimulus to cerebral cortex. Neurosurgery 1987, 20:74-93.
46. Shimazu H., Maier M.A., Cerri G., Kirkwood P.A., Lemon R.N. Macaque ventral premotor cortex exerts powerful facilitation of motor cortex outputs to upper limb motoneurons. J Neurosci 2004, 24:1200-1211.
47. Ziemann U., Muellbacher W., Hallett M., Cohen L.G. Modulation of practice-dependent plasticity in human motor cortex. Brain 2001, 124:1171-1181.
48. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Pilato F., Zito G., et al. Ketamine increases motor cortex excitability to transcranial magnetic stimulation. J Physiol 2003, 485-496. 547.
49. Hodgkin A.L., Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol 1952, 116:228-232.
50. Douglas R., Martin K. Neocortex. The synaptic organisation of the brain 1998, 459-509. Oxford University Press, New York. G.M. Shepard (Ed.).